| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9774 |
| Human Intestinal Absorption | HIA+ | 0.9684 |
| Caco-2 Permeability | Caco2+ | 0.8609 |
| P-glycoprotein Substrate | Substrate | 0.8572 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8438 |
| Inhibitor | 0.6867 |
| Renal Organic Cation Transporter | Inhibitor | 0.6996 |
| Distribution |
| Subcellular localization | Lysosome | 0.7225 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7921 |
| CYP450 2D6 Substrate | Substrate | 0.7890 |
| CYP450 3A4 Substrate | Substrate | 0.5875 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9412 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9188 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.9302 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.7193 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9286 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7449 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9242 |
| Inhibitor | 0.8222 |
| AMES Toxicity | Non AMES toxic | 0.9180 |
| Carcinogens | Non-carcinogens | 0.9297 |
| Fish Toxicity | High FHMT | 0.9459 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9444 |
| Honey Bee Toxicity | Low HBT | 0.7947 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | II | 0.4949 |
| Carcinogenicity (Three-class) | Non-required | 0.7437 |